3/20/2015 – Biogen Reports Its Alzheimer’s Drug Sharply Slowed Cognitive Decline

An experimental drug for Alzheimer’s disease sharply slowed the decline in mental function in a small clinical trial, researchers reported Friday, reviving hopes for an approach to therapy that until now has experienced repeated failures.

Read the full article at The New York Times.